Botox Warning Issued by FDA After Cases of Rare Disease Identified
Summary
The FDA has warned companies against selling unapproved Botox products because they are linked to a rare but serious illness called botulism. The agency has sent warning letters to 18 websites selling these potentially dangerous products, which have caused illnesses in at least 22 individuals.Key Facts
- The FDA issued warnings to 18 websites for selling unapproved Botox.
- Unapproved Botox can cause botulism, a serious illness that can be deadly.
- Botulism symptoms include muscle weakness, trouble swallowing, and breathing difficulties.
- 22 people reported botulism-related illnesses in 11 states from November 2023 to March 2024.
- The illnesses mainly affected women aged 25 to 59 who received injections outside licensed facilities.
- 11 individuals required hospitalization due to the conditions.
- The FDA advises consumers to use only FDA-approved Botox products and seek treatment from licensed professionals.
- If symptoms of botulism appear after an injection, immediate medical attention is recommended.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
